Drug:
Reaction: DYSPNOEA
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26542482 |
US |
74 | 2 |
Dyspnoea, Serum ferritin decreased, Anaemia, |
||||
BEMPEDOIC ACID, EVOLOCUMAB, |
||||
| 302 | 26542510 |
US |
2 | |
Headache, Dyspnoea, Wrong technique in product usage process, Inappropriate schedule of product administration, |
||||
BEMPEDOIC ACID, |
||||
| 303 | 26542610 |
US |
51 | 1 |
Heart rate increased, Dyspnoea, Sepsis, Illness, Insurance issue, Product dose omission issue, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 304 | 26542687 |
US |
2 | |
Contusion, Dyspnoea, |
||||
REMIBRUTINIB, |
||||
| 305 | 26542692 |
US |
75 | 2 |
Dizziness, Feeling abnormal, Dyspnoea, Swelling face, |
||||
TREPROSTINIL, TREPROSTINIL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), VITAMIN C, BRIMONIDINE TARTRATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, TRAVOPROST, TRAVOPROST (ISOMER FREE), ACETAMINOPHEN, SERTRALINE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, ALENDRONATE SODIUM, ALBUTEROL SULFATE, LISINOPRIL, CEPHALEXIN, FLUOROMETHOLONE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, DORZOLAMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, MIRABEGRON, |
||||
| 306 | 26542715 |
GB |
61 | 2 |
Muscle spasms, Dyspnoea, Erythema, Taste disorder, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 307 | 26542759 |
EU |
78 | 2 |
Cardiac failure, Overdose, Dyspnoea, |
||||
MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, FLUCONAZOLE, FLUCONAZOLE, FLUCONAZOLE, DAPAGLIFLOZIN, EPLERENONE, BISOPROLOL FUMARATE, RIVAROXABAN, |
||||
| 308 | 26542800 |
US |
||
Dyspnoea, Nausea, Chest pain, |
||||
FERRIC DERISOMALTOSE, |
||||
| 309 | 26542985 |
US |
80 | 1 |
Dyspnoea, Incorrect dose administered, Heart rate decreased, Drug hypersensitivity, Tremor, |
||||
MOLNUPIRAVIR, |
||||
| 310 | 26543063 |
US |
2 | |
Medication error, Product dose omission issue, No adverse event, Medication error, Medication error, Asthenia, Amnesia, Dyspnoea, Product quality issue, |
||||
ALBUTEROL SULFATE, |
||||
| 311 | 26543163 |
GB |
67 | 2 |
Chest discomfort, Myopathy, Muscle spasms, Dyspnoea, |
||||
AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LANSOPRAZOLE, TIOTROPIUM BROMIDE, |
||||
| 312 | 26543182 |
US |
66 | 2 |
Anaphylactic reaction, Dyspnoea, Drug hypersensitivity, |
||||
GLATIRAMER ACETATE, |
||||
| 313 | 26543188 |
US |
||
Alopecia, Application site reaction, Chronic spontaneous urticaria, Depression, Dyspnoea, Haemorrhage, Headache, Hepatic enzyme increased, Tachycardia, Insomnia, Intervertebral disc protrusion, Malaise, Paraesthesia, Primary biliary cholangitis, Pruritus, Scratch, Skin burning sensation, Skin lesion, Skin plaque, Spinal meningeal cyst, Stress, Erythema, Product dose omission issue, Drug ineffective, Incorrect dose administered, Inappropriate schedule of product administration, Wrong technique in product usage process, |
||||
OMALIZUMAB, |
||||
| 314 | 26543376 |
US |
71 | 2 |
Dyspnoea, Hypersensitivity, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LORATADINE, LORATADINE ORAL, MELOXICAM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 315 | 26543379 |
US |
2 | |
Dyspnoea, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 316 | 26543487 |
US |
63 | 2 |
Dyspnoea, Gait disturbance, Weight increased, Drug titration error, Off label use, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 317 | 26543577 |
US |
1 | |
Fluid retention, Dyspnoea, Cardiac failure congestive, |
||||
DAROLUTAMIDE, RELUGOLIX, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, MELATONIN, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, FINASTERIDE, FUROSEMIDE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LISINOPRIL, METOLAZONE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MIRTAZAPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TASIMELTEON, TERAZOSIN, TERAZOSIN HYDROCHLORIDE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, |
||||
| 318 | 26543591 |
CO |
24 | |
Hospitalisation, Dyspnoea, Drug abuse, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 319 | 26543625 |
US |
2 | |
Cough, Dyspnoea, Product dose omission issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 320 | 26543669 |
US |
60 | 1 |
Dyspnoea, Incorrect dose administered, |
||||
RELUGOLIX, ABIRATERONE ACETATE, ABIRATERONE, PREDNISONE, |
||||
| 321 | 26543775 |
US |
1 | |
Fall, Dyspnoea, Limb injury, Product physical issue, Product dose omission issue, |
||||
GLYCOPYRROLATE AND FORMOTEROL FUMARATE, |
||||
| 322 | 26543783 |
EU |
77 | 1 |
Pneumonia, Fibrosis, Forced vital capacity decreased, Dyspnoea, Lung diffusion test decreased, Drug intolerance, Diarrhoea, |
||||
PIRFENIDONE, NINTEDANIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, PANTOPRAZOLE, IPRATROPIUM BROMIDE, PREDNISONE, ROSUVASTATIN, URSODIOL, URSOSIOL, |
||||
| 323 | 26543917 |
US |
76 | 2 |
Dyspnoea, Product dose omission issue, Device use issue, Overdose, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 324 | 26543926 |
BR |
50 | 1 |
Transient ischaemic attack, Sensory disturbance, Malaise, Drug ineffective, Amnesia, Depressive symptom, Dyspnoea, Anxiety, |
||||
LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 325 | 26543941 |
RU |
53 | 2 |
Oedema, Pyrexia, Dyspnoea, Blood pressure decreased, Hallucination, Diarrhoea, Malaise, Blood creatinine increased, Renal impairment, |
||||
ENTRECTINIB, |
||||
| 326 | 26544017 |
GB |
67 | 2 |
Chest discomfort, Myopathy, Muscle spasms, Dyspnoea, |
||||
AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LANSOPRAZOLE, TIOTROPIUM BROMIDE, |
||||
| 327 | 26544061 |
EU |
28 | 2 |
Dyspnoea, |
||||
OLANZAPINE, |
||||
| 328 | 26544202 |
IN |
2 | |
Malignant pleural effusion, Dyspnoea, Blood pressure increased, Asthenia, Cough, |
||||
RIBOCICLIB, |
||||
| 329 | 26544205 |
EU |
78 | 2 |
Cardiac failure, Overdose, Dyspnoea, |
||||
FLUCONAZOLE, FLUCONAZOLE, FLUCONAZOLE, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, DAPAGLIFLOZIN, EPLERENONE, BISOPROLOL FUMARATE, RIVAROXABAN, |
||||
| 330 | 26544314 |
GB |
80 | 1 |
Infection, Dyspnoea, Balance disorder, Cataract, Dry mouth, Paraesthesia, Muscular weakness, Peripheral swelling, |
||||
NIVOLUMAB, |
||||
| 331 | 26544319 |
EU |
94 | 2 |
Haematoma, Peripheral swelling, Dyspnoea, |
||||
PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MIRABEGRON, |
||||
| 332 | 26544344 |
US |
2 | |
Dyspnoea, Oral candidiasis, Visual impairment, Device issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 333 | 26544348 |
US |
||
Hypoaesthesia, Chest pain, Abdominal pain upper, Dyspnoea, |
||||
FERRIC DERISOMALTOSE, |
||||
| 334 | 26544352 |
US |
||
Dyspnoea, Vomiting, Nausea, |
||||
FERRIC DERISOMALTOSE, |
||||
| 335 | 26544378 |
CA |
74 | 2 |
Adverse event, Arthralgia, Cytokine release syndrome, Diarrhoea, Dysphonia, Dyspnoea, Fatigue, Headache, Hypoaesthesia, Illness, Injection site pruritus, Injection site rash, Joint stiffness, Migraine, Nausea, Oedema, Oedema peripheral, Peripheral swelling, Productive cough, Rash, Rectal spasm, Thrombosis, Transfusion, Vomiting, Intentional product use issue, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, TECLISTAMAB-CQYV, TECLISTAMAB-CQYV, TECLISTAMAB-CQYV, TECLISTAMAB-CQYV, TECLISTAMAB-CQYV, TECLISTAMAB-CQYV, TECLISTAMAB-CQYV, TECLISTAMAB-CQYV, CYANOCOBALAMIN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, RABEPRAZOLE, RIVAROXABAN, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
| 336 | 26544574 |
|||
Lethargy, Hypotension, Dizziness, Dyspnoea, Cough, Ankylosing spondylitis, Condition aggravated, Presyncope, Pneumonia, Nausea, Interstitial lung disease, Clostridium difficile infection, Disability assessment scale score increased, Circumstance or information capable of leading to medication error, Product distribution issue, |
||||
ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, SULFASALAZINE, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, ERGOCALCIFEROL, SEMAGLUTIDE, |
||||
| 337 | 26544600 |
VN |
24 | 1 |
Transplant failure, Trichosporon infection, Pyrexia, Respiratory rate increased, Dyspnoea, Wheezing, Neutropenia, |
||||
CYCLOSPORINE, BUSULFAN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AMPHOTERICIN B, |
||||
| 338 | 26544630 |
GB |
38 | 2 |
Sinus headache, Dyspnoea, Pulmonary pain, Swelling of nose, Sinus pain, Headache, Constipation, |
||||
GABAPENTIN, BISOPROLOL FUMARATE, |
||||
| 339 | 26544646 |
CA |
84 | 1 |
Blood pressure diastolic increased, Hot flush, Blood pressure abnormal, Bone pain, Hip fracture, Dyspnoea, |
||||
TRIPTORELIN PAMOATE, TRIPTORELIN PAMOATE, TRIPTORELIN PAMOATE, TRIPTORELIN PAMOATE, TRIPTORELIN PAMOATE, |
||||
| 340 | 26544648 |
TN |
37 | 2 |
Myasthenia gravis crisis, Dysphagia, Mastication disorder, Eyelid ptosis, Diplopia, Dyspnoea, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 341 | 26544787 |
CN |
68 | 1 |
Parkinsonism, Gastrooesophageal reflux disease, Hepatic mass, Chest discomfort, Disease progression, Nausea, Vomiting, Metastases to central nervous system, Lung neoplasm, Liver injury, Biliary obstruction, Malnutrition, COVID-19, Oxygen saturation decreased, Death, Dyspnoea, Cholelithiasis, Weight decreased, Pancreatic disorder, Cholestasis, |
||||
BEVACIZUMAB, |
||||
| 342 | 26544799 |
70 | 1 | |
Dyspnoea, Sleep disorder, Sinusitis, |
||||
BRENSOCATIB, |
||||
| 343 | 26544823 |
US |
79 | 2 |
Dyspnoea, Device malfunction, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 344 | 26544881 |
CA |
51 | |
Asthma, Blood pressure increased, Decreased appetite, Dysphagia, Dyspnoea, Effusion, Gastrointestinal disorder, Hypersensitivity, Irritable bowel syndrome, Malaise, Memory impairment, Nasal congestion, Oropharyngeal pain, Pharyngeal swelling, Respiratory disorder, SARS-CoV-2 test positive, Seasonal allergy, Smoke sensitivity, Sinusitis, Viral pharyngitis, Sneezing, Bronchitis, COVID-19, Cough, Diarrhoea, Fatigue, Headache, Therapeutic product effect incomplete, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DESOXIMETASONE, MOMETASONE FUROATE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
| 345 | 26544972 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, RITUXIMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CEFADROXIL, CEFADROXIL, CEFADROXIL, |
||||
| 346 | 26544982 |
GB |
82 | 2 |
Fatigue, Dyspnoea, Myalgia, |
||||
APIXABAN, BUMETANIDE, LISINOPRIL, |
||||
| 347 | 26545116 |
EU |
||
Blindness, Tremor, Hyperhidrosis, Dyspnoea, |
||||
DEGARELIX, DEGARELIX, |
||||
| 348 | 26545216 |
EU |
59 | 1 |
Lymphoma, Testicular neoplasm, Richter^s syndrome, Submandibular gland enlargement, Dysphonia, Night sweats, Stress, General physical health deterioration, Dyspnoea exertional, Dyspnoea, Pain in extremity, Off label use, Asthenia, |
||||
PIRTOBRUTINIB, VENETOCLAX, RITUXIMAB, |
||||
| 349 | 26545221 |
US |
2 | |
Malaise, Chest pain, Dyspnoea, Dyspnoea, Feeling hot, Flushing, Flushing, Oropharyngeal discomfort, Oropharyngeal discomfort, Vomiting, Vomiting, Nausea, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, |
||||
| 350 | 26545264 |
CN |
2 | |
Respiratory rate increased, Pain, Loss of consciousness, Vomiting, Tremor, Dyspnoea, Pallor, Blood potassium decreased, Trace element deficiency, Hypoglycaemia, Decreased appetite, Prescription drug used without a prescription, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 351 | 26545305 |
CN |
87 | 1 |
Chest pain, Blood pressure increased, Dyspnoea, Agitation, Flat affect, Cardiac disorder, |
||||
SACUBITRIL AND VALSARTAN, |
||||
| 352 | 26545333 |
44 | 2 | |
Hospitalisation, Chronic respiratory failure, Pulmonary embolism, Right ventricular failure, Asthma, Hypothyroidism, Dyspnoea, Influenza like illness, Cough, Pyrexia, Productive cough, Headache, Dyspnoea, Oxygen saturation decreased, |
||||
RIOCIGUAT, RIOCIGUAT, OXYGEN, 0XYGEN, |
||||
| 353 | 26545411 |
CN |
1 | |
Pleural effusion, Cough, Dyspnoea, |
||||
LORLATINIB, |
||||
| 354 | 26545462 |
BR |
76 | 1 |
Hypoxia, Tremor, Feeling cold, Dyspnoea, Hypertension, Chills, |
||||
RITUXIMAB-PVVR, RITUXIMAB, OXALIPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, LOSARTAN, AMLODIPINE, |
||||
| 355 | 26545527 |
CN |
24 | 2 |
Discomfort, Chest discomfort, Dyspnoea, Sinus arrhythmia, Palpitations, Haematemesis, Abdominal pain upper, Dizziness, Fatigue, Nausea, |
||||
TIRZEPATIDE, |
||||
| 356 | 26545814 |
53 | 2 | |
Dysgeusia, Electric shock sensation, Pain in extremity, Nausea, Chills, Diarrhoea, Back pain, Muscle tightness, Muscle spasms, Muscular weakness, Paraesthesia, Brain fog, Vitreous floaters, Dry eye, Eye irritation, Arthralgia, Abdominal pain, Dizziness, Presyncope, Dyspnoea, Body temperature decreased, Tinnitus, Visual impairment, Nontherapeutic agent blood positive, Suspected product quality issue, |
||||
GADOBUTROL, THYROID, PORCINE, |
||||
| 357 | 26545851 |
AU |
50 | 2 |
Dyspnoea, Neutropenia, Hypokalaemia, Cough, Headache, Decreased appetite, Musculoskeletal chest pain, Oxygen saturation decreased, Wheezing, Oropharyngeal pain, Constipation, |
||||
ALBUTEROL SULFATE, CELECOXIB, CICLESONIDE, CLOZAPINE, CLOZAPINE, CHOLESTYRAMINE, FENOFIBRATE, FENOFIBRATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, NICOTINE, NICOTINE POLACRILEX, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREGABALIN, |
||||
| 358 | 26545888 |
US |
74 | 2 |
Feeding disorder, Muscle spasms, Abnormal faeces, Faeces discoloured, Mobility decreased, Pain, Hiatus hernia, Dyspnoea, Balance disorder, Limb discomfort, Product use issue, Fatigue, Dysgeusia, Gastrooesophageal reflux disease, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 359 | 26545916 |
|||
Seizure, Confusional state, Fatigue, Dyspnoea, Oxygen saturation decreased, Staring, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, LEVETIRACETAM, SILDENAFIL CITRATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 360 | 26546003 |
IN |
2 | |
Pain, Dyspnoea, |
||||
DURVALUMAB, |
||||
| 361 | 26546021 |
US |
63 | 2 |
Dyspnoea, Influenza, Asthma, Emphysema, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 362 | 26546070 |
US |
85 | 2 |
Dyspnoea, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 363 | 26546083 |
US |
74 | 2 |
Hypertension, Heart rate decreased, Dyspnoea, Hypoaesthesia, Nervousness, Joint swelling, Eye swelling, Sneezing, Muscle spasms, Pain in extremity, Diarrhoea, Chest discomfort, Insomnia, |
||||
LENVATINIB, ATENOLOL, |
||||
| 364 | 26546244 |
EG |
62 | 2 |
Syncope, Neutrophil count decreased, Blood calcium increased, Off label use, Chest pain, Constipation, Heart rate increased, Dyspnoea, Pain, Decreased immune responsiveness, Abdominal pain upper, Abdominal pain lower, Diarrhoea, Platelet count decreased, Dyspepsia, Dizziness, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, VERAPAMIL HYDROCHLORIDE, ROSUVASTATIN, ANASTROZOLE, |
||||
| 365 | 26546272 |
VN |
2 | |
Dyspnoea, Chest pain, Pyrexia, Oedema peripheral, Acinetobacter infection, Postoperative wound infection, Leukopenia, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 366 | 26546274 |
US |
59 | 2 |
Therapeutic response shortened, Dyspnoea, |
||||
VALBENAZINE, VALBENAZINE, ESKETAMINE HYDROCHLORIDE, BUPROPION, VILAZODONE HYDROCHLORIDE, LUMATEPERONE, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 367 | 26546302 |
77 | 1 | |
Altered state of consciousness, Acute kidney injury, Capillary leak syndrome, Dyspnoea, Rales, Sluggishness, Oedema peripheral, |
||||
GEMCITABINE HYDROCHLORIDE, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEVOLEUCOVORIN INJECTION, LEVOLEUCOVORIN CALCIUM, LEVOLEUCOVORIN, PANCRELIPASE, AMLODIPINE BESYLATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DULAGLUTIDE, LANSOPRAZOLE, |
||||
| 368 | 26546524 |
GB |
75 | |
Respiratory failure, Diplopia, IIIrd nerve paralysis, Myocarditis-myositis-myasthenia gravis overlap syndrome, Eyelid ptosis, Immunotoxicity, Dyspnoea, |
||||
LENVATINIB, LENVATINIB, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 369 | 26552382 |
61 | 1 | |
Dyspnoea, |
||||
PALBOCICLIB, CARVEDILOL, FUROSEMIDE, EMPAGLIFLOZIN, LETROZOLE, LETROZOLE TABLETS, LOSARTAN POTASSIUM, LOSARTAN, PANTOPRAZOLE, SPIRONOLACTONE, |
||||
| 370 | 26552393 |
78 | 1 | |
Diarrhoea, Fatigue, Dyspnoea, |
||||
LENALIDOMIDE, |
||||
| 371 | 26553237 |
2 | ||
Dizziness, Dyspnoea, Fluid retention, Chest pain, Myalgia, |
||||
MACITENTAN, |
||||
| 372 | 26554315 |
13 | 2 | |
Depression, Anxiety, Suicidal ideation, Intentional self-injury, Agitation, Aggression, Memory impairment, Disturbance in attention, Disorientation, Dysphemia, Insomnia, Personality change, Dyspnoea, |
||||
MONTELUKAST, MONTELUKAST, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LORATADINE, LORATADINE TABLET, |
||||
| 373 | 26554418 |
|||
Headache, Dyspnoea, |
||||
BOTULINUM TOXIN TYPE A, |
||||
| 374 | 26554427 |
|||
Rash, Rash, Rash, Rash, Dyspnoea, Infusion related reaction, |
||||
CARBOPLATIN, CARBOPLATIN, |
||||
| 375 | 26554649 |
|||
Infusion related reaction, Palpitations, Dyspnoea, Abdominal pain lower, Pruritus, |
||||
FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, |
||||
| 376 | 26554707 |
84 | 2 | |
Chest pain, Dyspnoea, Confusional state, Abdominal pain, Balance disorder, Sinus congestion, Cough, Asthenia, |
||||
TOCILIZUMAB, |
||||
| 377 | 26554716 |
33 | 2 | |
Urticaria, Dyspnoea, Pruritus, |
||||
| 378 | 26558212 |
62 | 2 | |
Facial paresis, Visual impairment, Muscular weakness, Dyspnoea, |
||||
ONABOTULINUMTOXINA, ESOMEPRAZOLE MAGNESIUM, |
||||
| 379 | 26535839 |
US |
73 | 1 |
Dyspnoea, Productive cough, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MAGNESIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, PRAVASTATIN SODIUM, ERGOCALCIFEROL, LOSARTAN POTASSIUM, LOSARTAN, TADALAFIL, ALBUTEROL SULFATE, HYDROCHLOROTHIAZIDE, BENZONATATE, OXYGEN, 0XYGEN, |
||||
| 380 | 26535843 |
US |
2 | |
Rhinorrhoea, Sinusitis, Dyspnoea exertional, Decreased activity, Wheezing, Nasal discharge discolouration, Oral herpes, Cough, Dyspnoea, Dysstasia, Fatigue, Inappropriate schedule of product administration, Patient dissatisfaction with treatment, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ACETAMINOPHEN, MAGNESIUM, ERGOCALCIFEROL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, RISPERIDONE, ALENDRONATE SODIUM, PROPYLENE GLYCOL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DEXLANSOPRAZOLE, MUPIROCIN, MUPIROCIN CALCIUM, VITAMIN C, OXYGEN, 0XYGEN, DIVALPROEX SODIUM, AZITHROMYCIN DIHYDRATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 381 | 26535914 |
US |
2 | |
Gait inability, Speech disorder, Dyspnoea, Visual impairment, Hypoaesthesia, Tremor, Musculoskeletal disorder, Dissociation, Seizure, Botulism, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 382 | 26536028 |
US |
63 | 1 |
Dyspnoea, |
||||
| 383 | 26536031 |
EU |
26 | 1 |
Anaphylactic reaction, Cardiac flutter, Blood pressure decreased, Sensation of foreign body, Pharyngeal oedema, Chest discomfort, Dyspnoea, Salivary hypersecretion, Dysphagia, Paraesthesia oral, Product administration error, |
||||
ISOTRETINOIN, |
||||
| 384 | 26536043 |
US |
63 | 2 |
Respiratory failure, Hypoxia, Tachypnoea, Dyspnoea, PaO2/FiO2 ratio decreased, |
||||
| 385 | 26536131 |
2 | ||
Rash, Dyspnoea, |
||||
DATOPOTAMAB DERUXTECAN, |
||||
| 386 | 26536200 |
2 | ||
Haemorrhage subcutaneous, Chest discomfort, Abdominal pain lower, Abdominal distension, Eructation, Ear haemorrhage, Dyspnoea, |
||||
HYDROXYUREA, HYDROXYUREA, HYDROXYUREA, HYDROXYUREA, |
||||
| 387 | 26536260 |
US |
46 | 2 |
Dyspnoea, Device dislocation, Device breakage, |
||||
TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TADALAFIL, KETAMINE HYDROCHLORIDE, CLONIDINE, KETOPROFEN, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, AMITRIPTYLINE HYDROCHLORIDE, GABAPENTIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 388 | 26536282 |
EG |
63 | 2 |
Oxygen saturation decreased, Dyspnoea, Heart rate increased, Erythema, Chills, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OXYGEN, 0XYGEN, |
||||
| 389 | 26536299 |
32 | ||
Intentional overdose, Dyspnoea, Compartment syndrome, Haemodynamic instability, Reperfusion injury, Ischaemia, |
||||
AMLODIPINE, |
||||
| 390 | 26536303 |
US |
56 | 1 |
Dyspnoea, Seasonal allergy, Swelling face, |
||||
CLONAZEPAM, QUETIAPINE, RASAGILINE MESYLATE, RASAGILINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 391 | 26536392 |
AU |
50 | 2 |
Neutropenia, Dyspnoea, Oropharyngeal pain, Wheezing, |
||||
CELECOXIB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FENOFIBRATE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREGABALIN, CICLESONIDE, CHOLESTYRAMINE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, NICOTINE, NICOTINE POLACRILEX, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ALBUTEROL SULFATE, |
||||
| 392 | 26536447 |
IN |
1 | |
Drug-induced liver injury, Ascites, General physical health deterioration, Dyspnoea, |
||||
DURVALUMAB, |
||||
| 393 | 26536469 |
CN |
74 | 2 |
Chills, Tachycardia, Hypertension, Chest discomfort, Pallor, Dyspnoea, |
||||
ALBUMIN HUMAN, FUROSEMIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CEFUROXIME SODIUM, CEFUROXIME SODIUM, VITAMIN C, VITAMIN C, |
||||
| 394 | 26536502 |
CA |
78 | 2 |
Aspiration, Abdominal pain upper, Upper respiratory tract infection, Pneumonia, Pulmonary fibrosis, Lower respiratory tract infection, Hypoxia, Bronchiectasis, Anaemia, Asthma, Blood calcium increased, Blood test abnormal, Bronchopulmonary aspergillosis allergic, Gastrooesophageal reflux disease, Haemoptysis, Lung opacity, Musculoskeletal stiffness, Obstructive airways disorder, Pleural effusion, Rales, Sputum discoloured, Total lung capacity decreased, Wheezing, Pain, General physical health deterioration, Pulmonary mass, Dyspnoea, Oedema peripheral, Pyrexia, Constipation, Asthenia, Fatigue, Tremor, Headache, Blood creatinine increased, Transaminases increased, Liver function test increased, Drug hypersensitivity, Cough, Product dose omission issue, Drug ineffective, Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, ROSUVASTATIN CALCIUM, CANDESARTAN CILEXETIL, DEXLANSOPRAZOLE, LANSOPRAZOLE, MORPHINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, EFINACONAZOLE, NITROGLYCERIN, BUDESONIDE, |
||||
| 395 | 26536592 |
US |
74 | 2 |
Dyspnoea, Product dose omission issue, Device delivery system issue, |
||||
| 396 | 26536725 |
US |
68 | |
Dyspnoea, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 397 | 26536734 |
US |
8 | |
Chest discomfort, Dyspnoea, Off label use, Infusion related reaction, |
||||
DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, |
||||
| 398 | 26536813 |
US |
2 | |
Feeling abnormal, Dyspnoea, Muscular weakness, |
||||
| 399 | 26536831 |
CA |
67 | 2 |
Cough, Dyspnoea, Hypoxia, Lung opacity, Oxygen therapy, Sputum increased, |
||||
PEMBROLIZUMAB, |
||||
| 400 | 26536887 |
US |
12 | 1 |
Dyspnoea, Weight increased, |
||||
ELIGLUSTAT, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
